Influence of the HLA-Cw6 Allele and IFIH1/MDA5 Gene Variants on the Cardiometabolic Risk Profile of Patients with Psoriatic Disease
BACKGROUND: Cardiovascular comorbidity is a common companion of psoriasis and psoriatic arthritis (PsA). Recently, a significant link has been found between the HLA-Cw6 allele and a better cardiometabolic profile in these patients. We aimed to check this finding in our setting.
METHODS: A cross-sectional observational study (n: 572 psoriasis patients, 30% with PsA) was conducted. Different study variables were collected in detail, as well as classic cardiometabolic risk factors. The distribution of the HLA-Cw6 allele and the IFIH1/MDA5 gene variants previously linked to disease risk were determined in the study cohort and stratified according to the cardiometabolic comorbidity. Linear and logistic regression models were constructed to analyze these associations.
RESULTS: The study cohort included 309 men and 263 women, with a mean age of 46.7 years (SD 14.5) and a mean disease duration of 19.4 years (SD 14.8). We confirmed the known association between HLA-Cw6 and type I psoriasis (familial, severe, and early onset). Psoriasis severity (OR: 2.14), female sex (OR: 1.63), and the IFIH1/MDA5 rs1990760 TT genotype (OR: 1.62) were significantly related to PsA, while HLA-Cw6 was protective (OR: 0.65). HLA-Cw6 carriers showed a lower waist perimeter, lower BMI, and lower risk of both hypertension (OR: 0.52, p < 0.001) and diabetes (OR: 0.36, p < 0.001), but these findings were no longer apparent upon adjusting the regression models. No IFIH1/MDA5 gene variant was associated with any cardiometabolic risk factor.
CONCLUSIONS: The influence of HLA-Cw6 on the cardiometabolic risk profile of psoriatic patients seems to be explained by other factors (age, sex, duration of the disease or arthritis) and not by this biomarker itself.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Journal of clinical medicine - 13(2024), 3 vom: 01. Feb. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Queiro, Rubén [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cardiovascular risk |
---|
Anmerkungen: |
Date Revised 12.02.2024 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/jcm13030845 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368270319 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM368270319 | ||
003 | DE-627 | ||
005 | 20240212232137.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240210s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/jcm13030845 |2 doi | |
028 | 5 | 2 | |a pubmed24n1289.xml |
035 | |a (DE-627)NLM368270319 | ||
035 | |a (NLM)38337541 | ||
035 | |a (PII)845 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Queiro, Rubén |e verfasserin |4 aut | |
245 | 1 | 0 | |a Influence of the HLA-Cw6 Allele and IFIH1/MDA5 Gene Variants on the Cardiometabolic Risk Profile of Patients with Psoriatic Disease |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 12.02.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a BACKGROUND: Cardiovascular comorbidity is a common companion of psoriasis and psoriatic arthritis (PsA). Recently, a significant link has been found between the HLA-Cw6 allele and a better cardiometabolic profile in these patients. We aimed to check this finding in our setting | ||
520 | |a METHODS: A cross-sectional observational study (n: 572 psoriasis patients, 30% with PsA) was conducted. Different study variables were collected in detail, as well as classic cardiometabolic risk factors. The distribution of the HLA-Cw6 allele and the IFIH1/MDA5 gene variants previously linked to disease risk were determined in the study cohort and stratified according to the cardiometabolic comorbidity. Linear and logistic regression models were constructed to analyze these associations | ||
520 | |a RESULTS: The study cohort included 309 men and 263 women, with a mean age of 46.7 years (SD 14.5) and a mean disease duration of 19.4 years (SD 14.8). We confirmed the known association between HLA-Cw6 and type I psoriasis (familial, severe, and early onset). Psoriasis severity (OR: 2.14), female sex (OR: 1.63), and the IFIH1/MDA5 rs1990760 TT genotype (OR: 1.62) were significantly related to PsA, while HLA-Cw6 was protective (OR: 0.65). HLA-Cw6 carriers showed a lower waist perimeter, lower BMI, and lower risk of both hypertension (OR: 0.52, p < 0.001) and diabetes (OR: 0.36, p < 0.001), but these findings were no longer apparent upon adjusting the regression models. No IFIH1/MDA5 gene variant was associated with any cardiometabolic risk factor | ||
520 | |a CONCLUSIONS: The influence of HLA-Cw6 on the cardiometabolic risk profile of psoriatic patients seems to be explained by other factors (age, sex, duration of the disease or arthritis) and not by this biomarker itself | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a HLA-Cw6 | |
650 | 4 | |a IFIH1/MDA5 gene | |
650 | 4 | |a cardiovascular risk | |
650 | 4 | |a psoriasis | |
650 | 4 | |a psoriatic arthritis | |
700 | 1 | |a Braña, Ignacio |e verfasserin |4 aut | |
700 | 1 | |a Pardo, Estefanía |e verfasserin |4 aut | |
700 | 1 | |a Loredo, Marta |e verfasserin |4 aut | |
700 | 1 | |a Burger, Stefanie |e verfasserin |4 aut | |
700 | 1 | |a González Del Pozo, Pablo |e verfasserin |4 aut | |
700 | 1 | |a Alvarez, Paula |e verfasserin |4 aut | |
700 | 1 | |a Fernández-Bretón, Eva |e verfasserin |4 aut | |
700 | 1 | |a Coto, Pablo |e verfasserin |4 aut | |
700 | 1 | |a Coto, Eliecer |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of clinical medicine |d 2012 |g 13(2024), 3 vom: 01. Feb. |w (DE-627)NLM230666310 |x 2077-0383 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2024 |g number:3 |g day:01 |g month:02 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/jcm13030845 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2024 |e 3 |b 01 |c 02 |